Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OmniAb, Inc.OABI · Entity 5294 | 10% owner | June 28, 2024 | July 02, 2024 |
| Organogenesis Holdings Inc.ORGO · Entity 6275 | 10% owner | November 12, 2024 | November 19, 2024 |
| RVL Pharmaceuticals plcRVLP · Entity 108806 | Director · 10% owner | January 27, 2023 | January 30, 2023 |
| Syneos Health, Inc.INCR · Entity 109360 | Director · 10% owner | May 23, 2017 | May 24, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OmniAb, Inc.
Report date June 28, 2024 · Filed July 02, 2024
Jointly reported with Avista Capital Managing Member V, LLC, Avista Capital Partners V GP, L.P., Avista Capital Partners V, L.P., Avista Capital Partners (Offshore) V, L.P., Dean Thompson, Tamaroff Joshua Alexander
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Notes | 15,992,372 |
Reported balance
After 2024-06-29 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2024-06-29 · Exercise / conversion · Acquired 66,668 · Balance 15,992,372 F17: Represents stock options exercised on a net share settlement basis. Accordingly, the Issuer is delivering an aggregate 7,111 shares of common stock to the Reporting Persons in connection with the option exercises, with no shares being sold externally. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Notes | 15,862,815 |
Reported balance
After 2024-06-29 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2024-06-29 · Tax withholding · Disposed 59,557 · Balance 15,862,815 F18: Represents the number of shares withheld by the Issuer to satisfy (i) the aggregate exercise price for the options and (ii) withholding taxes related to such exercise. No shares were sold by the Reporting Persons to satisfy the exercise price of the stock options. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Notes | 15,855,704 |
Reported balance
Holding disclosure · report date 2024-06-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 15,855,704 F7: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F8: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F9: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectSee Notes | 0 |
Reported balance
After 2024-06-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-06-28 · Disposition to issuer · Disposed 20,000 · Balance 0 F5: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F15: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectSee Notes | 0 |
Reported balance
After 2024-06-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-06-28 · Disposition to issuer · Disposed 35,538 · Balance 0 F4: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F15: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F10: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $4.19 · Expires 2034-06-18 | IndirectSee Notes | 0 |
Reported balance
After 2024-06-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-06-28 · Disposition to issuer · Disposed 40,000 · Balance 0 F16: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F6: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.35 · Expires 2032-12-01 | IndirectSee Notes | 66,668 |
Reported balance
After 2024-06-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-06-28 · Disposition to issuer · Disposed 133,333 · Balance 66,668 F16: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F14: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $4.81 · Expires 2033-06-23 | IndirectSee Notes | 40,000 |
Reported balance
Holding disclosure · report date 2024-06-28 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 40,000 F6: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2027-11-01 | IndirectSee Notes | 11,345,489 |
Reported balance
Holding disclosure · report date 2024-06-28 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 11,345,489 F12: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Agreement and Plan of Merger, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1, 2022. F13: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer").
F2: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer.
F3: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any.
F4: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023.
F5: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date.
F6: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date.
F7: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration.
F8: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement.
F9: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA).
F10: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024.
F11: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any.
F12: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Agreement and Plan of Merger, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1, 2022.
F13: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022.
F14: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff.
F15: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer.
F16: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer.
F17: Represents stock options exercised on a net share settlement basis. Accordingly, the Issuer is delivering an aggregate 7,111 shares of common stock to the Reporting Persons in connection with the option exercises, with no shares being sold externally.
F18: Represents the number of shares withheld by the Issuer to satisfy (i) the aggregate exercise price for the options and (ii) withholding taxes related to such exercise. No shares were sold by the Reporting Persons to satisfy the exercise price of the stock options.
Organogenesis Holdings Inc.
Report date November 12, 2024 · Filed November 19, 2024
Jointly reported with Avista Capital Managing Member VI, LLC, Avista Capital Partners VI GP, L.P., Avista Healthcare Partners III, L.P., AHP III Orchestra Holdings, L.P., Dean Thompson
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 2,178,317 |
Reported balance
Holding disclosure · report date 2024-11-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,178,317 F1: Represents shares of common stock directly held by Thompson Dean. F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 1,555,704 |
Reported balance
Holding disclosure · report date 2024-11-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,555,704 F2: Represents shares of common stock directly held by David Burgstahler. F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
| Series A Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee Explanation of Responses | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-12 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F4: The Convertible Preferred Stock is convertible at the option of a holder at any time into shares of common stock of the Issuer at an initial implied conversion price of $3.7917 per share; provided, however, the maximum number of shares of common stock issuable upon conversion of the Convertible Preferred Stock prior to receipt by the Issuer of stockholder approval (the "Requisite Stockholder Approval"), as contemplated by Nasdaq listing rules, is an aggregate of 26,502,042 shares of common stock (the "Share Cap"), and until the Requisite Stockholder Approval is obtained, no person or group of persons may beneficially own shares of common stock issuable upon conversion of the Convertible Preferred Stock in an amount greater than 19.99% of the then-outstanding shares of common stock.. The Convertible Preferred Stock has no expiration date. F5: Represents the number of shares of the Issuer's common stock that the Convertible Preferred Stock held by AHP III and AHP III Orchestra is currently convertible into due to the Share Cap. F3: Avista Healthcare Partners III, L.P. ("AHP III") directly owns 65,750 shares of the Issuer's Series A Convertible Preferred Stock, par value $0.0001 per share (the "Convertible Preferred Stock"), and AHP III Orchestra Holdings, L.P. ("AHP III Orchestra") directly owns 64,250 shares of Convertible Preferred Stock. Avista Capital Partners VI GP, L.P. ("ACP VI GP") is the general partner of each of AHP III and AHP III Orchestra, and Avista Capital Managing Member VI, LLC ("Avista Managing Member") is the general partners of ACP VI GP. Thompson Dean and David Burgstahler are the managers of Avista Managing Member. F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock directly held by Thompson Dean.
F2: Represents shares of common stock directly held by David Burgstahler.
F3: Avista Healthcare Partners III, L.P. ("AHP III") directly owns 65,750 shares of the Issuer's Series A Convertible Preferred Stock, par value $0.0001 per share (the "Convertible Preferred Stock"), and AHP III Orchestra Holdings, L.P. ("AHP III Orchestra") directly owns 64,250 shares of Convertible Preferred Stock. Avista Capital Partners VI GP, L.P. ("ACP VI GP") is the general partner of each of AHP III and AHP III Orchestra, and Avista Capital Managing Member VI, LLC ("Avista Managing Member") is the general partners of ACP VI GP. Thompson Dean and David Burgstahler are the managers of Avista Managing Member.
F4: The Convertible Preferred Stock is convertible at the option of a holder at any time into shares of common stock of the Issuer at an initial implied conversion price of $3.7917 per share; provided, however, the maximum number of shares of common stock issuable upon conversion of the Convertible Preferred Stock prior to receipt by the Issuer of stockholder approval (the "Requisite Stockholder Approval"), as contemplated by Nasdaq listing rules, is an aggregate of 26,502,042 shares of common stock (the "Share Cap"), and until the Requisite Stockholder Approval is obtained, no person or group of persons may beneficially own shares of common stock issuable upon conversion of the Convertible Preferred Stock in an amount greater than 19.99% of the then-outstanding shares of common stock.. The Convertible Preferred Stock has no expiration date.
F5: Represents the number of shares of the Issuer's common stock that the Convertible Preferred Stock held by AHP III and AHP III Orchestra is currently convertible into due to the Share Cap.
F6: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F7: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.
RVL Pharmaceuticals plc
Report date January 27, 2023 · Filed January 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Avista Capital investment fund | 0 |
Reported balance
After 2023-01-27 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2023-01-27 · Other · Disposed 1,032,995 · Balance 0 F1: Represents shares distributed in kind by Orbit Co-Invest III LLC ("Orbit III") to its members, on a pro rata basis, for no consideration. F2: Represents shares of the Issuer held by Orbit III. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit III. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to have shared voting and investment power with respect to the shares held by Orbit III. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Avista Capital investment fund | 23,730,864 |
Reported balance
Holding disclosure · report date 2023-01-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 23,730,864 F3: Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Burgstahler is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares distributed in kind by Orbit Co-Invest III LLC ("Orbit III") to its members, on a pro rata basis, for no consideration.
F2: Represents shares of the Issuer held by Orbit III. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit III. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to have shared voting and investment power with respect to the shares held by Orbit III. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
F3: Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Burgstahler is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Syneos Health, Inc.
Report date May 23, 2017 · Filed May 24, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 38,758 |
Reported balance
After 2017-05-23 transaction · row 1
1 source rowRow 1 · 2017-05-23 · Grant · Acquired 2,693 · Balance 38,758 F1: Represents an award of restricted stock units which vests in full one year from the grant date, subject to continued service on the Issuer's Board of Directors. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy trust | 3,648 |
Reported balance
Holding disclosure · report date 2017-05-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,648 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units which vests in full one year from the grant date, subject to continued service on the Issuer's Board of Directors.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ANGIODYNAMICS INC
Report date April 12, 2017 · Filed April 14, 2017
Section 16 reporting ended · disclosed 2017-04-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,446,413 |
Reported balance
After 2017-04-12 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-04-12 · Sale · Disposed 1,456,947 · Balance 1,446,413 F1: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 505,189 |
Reported balance
After 2017-04-12 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2017-04-12 · Sale · Disposed 508,869 · Balance 505,189 F2: Represents shares of the Issuer held by Navilyst Medical Co-Invest, LLC ("NM Co-Invest"). ACP GP is the manager of NM Co-Invest. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by NM Co-Invest. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 381,406 |
Reported balance
After 2017-04-12 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2017-04-12 · Sale · Disposed 384,184 · Balance 381,406 F3: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Each of ACP GP and ACP Offshore expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 23,988 |
Reported balance
Holding disclosure · report date 2017-04-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 23,988 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.
F2: Represents shares of the Issuer held by Navilyst Medical Co-Invest, LLC ("NM Co-Invest"). ACP GP is the manager of NM Co-Invest. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by NM Co-Invest. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.
F3: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. By virtue of this relationship, ACP GP may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Each of ACP GP and ACP Offshore expressly disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein.
Lantheus Holdings, Inc.
Report date September 07, 2017 · Filed September 11, 2017
Section 16 reporting ended · disclosed 2017-09-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 247,253 |
Reported balance
After 2017-09-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2017-09-07 · Sale · Disposed 88,543 · Balance 247,253 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.725, inclusive. The Reporting Person undertakes to provide to Lantheus Holdings, Inc., any security holder of Lantheus Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. F2: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 38,269 |
Reported balance
After 2017-09-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-09-07 · Sale · Disposed 14,415 · Balance 38,269 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.725, inclusive. The Reporting Person undertakes to provide to Lantheus Holdings, Inc., any security holder of Lantheus Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. F3: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 13,248 |
Reported balance
Holding disclosure · report date 2017-09-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 13,248 |
| Common StockSEC Table I · non-derivative | IndirectBy trust | 1,562 |
Reported balance
Holding disclosure · report date 2017-09-07 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,562 F4: The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.725, inclusive. The Reporting Person undertakes to provide to Lantheus Holdings, Inc., any security holder of Lantheus Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
F2: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.
F3: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Burgstahler may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Mr. Burgstahler expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.
F4: The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
WideOpenWest, Inc.
Report date August 06, 2019 · Filed August 06, 2019
Jointly reported with Avista Capital Managing Member, LLC, Avista Capital Partners III, L.P., Avista Capital Partners (Offshore) III, L.P., Avista Capital Partners (Offshore) III-A, L.P., ACP Racecar Co-Invest, LLC, ACP Racecar Co-Invest II, LLC, Tamaroff Joshua Alexander
Section 16 reporting ended · disclosed 2019-08-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 74,808 |
Reported balance
After 2019-08-06 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2019-08-06 · Other · Disposed 27,038,731 · Balance 74,808 F1: Pro rata distribution made for no consideration of (i) 5,189,636 shares made by Avista Capital Partners III, L.P., (ii) 1,531,596 shares made by Avista Capital Partners (Offshore) III, L.P., (iii) 1,362,097 shares made by Avista Capital Partners (Offshore) III-A, L.P., (iv) 18,059,208 shares made by ACP Racecar Co-Invest, LLC and (v) 896,194 shares made by ACP Racecar Co-Invest II, LLC (collectively, the "Avista Entities"), each to their respective partners. F3: Avista Capital Managing Member, LLC exercises voting and dispositive power over the Avista Entities and Avista Capital Holdings, L.P. F4: Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 47,494 |
Reported balance
After 2019-08-06 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2019-08-06 · Disposition to issuer · Disposed 27,314 · Balance 47,494 F2: Includes 27,314 restricted shares granted to David F. Burgstahler and Joshua Tamaroff collectively on May 10, 2019, which were assigned to Avista Capital Holdings, L.P. Such shares were forfeited in connection with Mr. Burgstahler's and Mr. Tamaroff's resignation from the Board of Directors of the Issuer, effective August 6, 2019. F3: Avista Capital Managing Member, LLC exercises voting and dispositive power over the Avista Entities and Avista Capital Holdings, L.P. F4: Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution made for no consideration of (i) 5,189,636 shares made by Avista Capital Partners III, L.P., (ii) 1,531,596 shares made by Avista Capital Partners (Offshore) III, L.P., (iii) 1,362,097 shares made by Avista Capital Partners (Offshore) III-A, L.P., (iv) 18,059,208 shares made by ACP Racecar Co-Invest, LLC and (v) 896,194 shares made by ACP Racecar Co-Invest II, LLC (collectively, the "Avista Entities"), each to their respective partners.
F2: Includes 27,314 restricted shares granted to David F. Burgstahler and Joshua Tamaroff collectively on May 10, 2019, which were assigned to Avista Capital Holdings, L.P. Such shares were forfeited in connection with Mr. Burgstahler's and Mr. Tamaroff's resignation from the Board of Directors of the Issuer, effective August 6, 2019.
F3: Avista Capital Managing Member, LLC exercises voting and dispositive power over the Avista Entities and Avista Capital Holdings, L.P.
F4: Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Tax withholdingCommon stock, par value $0.0001 per share | 59,557 | $3.75 | $223,338.75 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · nonDerivative · entry 3 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,862,815 F18 · shares: Represents the number of shares withheld by the Issuer to satisfy (i) the aggregate exercise price for the options and (ii) withholding taxes related to such exercise. No shares were sold by the Reporting Persons to satisfy the exercise price of the stock options. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 29, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionCommon stock, par value $0.0001 per share | 66,668 | $3.35 | $223,337.80 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · nonDerivative · entry 2 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,992,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F17 · shares: Represents stock options exercised on a net share settlement basis. Accordingly, the Issuer is delivering an aggregate 7,111 shares of common stock to the Reporting Persons in connection with the option exercises, with no shares being sold externally. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerStock Options · Derivative | 133,333 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 8 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 66,668 Underlying: Common stock, par value $0.0001 · 66,668 shares Expires 2032-12-01 F16 · kind: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F14 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F14 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F14 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. F14 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest in three substantially similar annual installments beginning on November 1, 2023. The Form 4s filed by the Reporting Persons on December 5, 2022 and December 13, 2022 incorrectly reported that 161,849 stock options and 161,849 shares of common stock underlying such stock options were issued to Mr. Tamaroff. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerStock Options · Derivative | 40,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 6 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 40,000 shares Expires 2034-06-18 F16 · kind: Represents the number of unvested stock options forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F6 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F6 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerRestricted Stock Units · Derivative | 35,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 5 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 35,538 shares Expires not disclosed F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F15 · kind: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F4 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · balance_after: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Disposition to issuerRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-077398 · tm2418740-1_4seq1.xml · derivative · entry 4 Avista Capital Managing Member V, LLC · CIK 0001957307 · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · 10% owner Burgstahler David F · CIK 0001374179 · 10% owner Dean Thompson · CIK 0001069096 · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Former 10% Owner and Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F15 · kind: Represents the number of unvested RSUs forfeited in connection with Mr. Tamaroff's resignation as a director of the Issuer. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a former director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: Mr. Tamaroff resigned as a director of the Issuer, effective as of June 28, 2024. As a result, Mr. Tamaroff is no longer subject to Section 16 reporting in connection with the securities of the Issuer. F3 · ownership.nature: ACP V Onshore directly holds 7,296,895 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,565,920 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff, in his capacity as a partner at an affiliate of the Avista Affiliates, had previously assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore were each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantStock Options · Derivative | 40,000 | $0.00 Strike: $4.19 | $0.00 |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · derivative · entry 5 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 40,000 Underlying: Common stock, par value $0.0001 · 40,000 shares Expires 2034-06-18 F7 · kind: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F7 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F7 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F7 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F7 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionRestricted Stock Units · Derivative | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · derivative · entry 4 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F4 · kind: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F5 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F5 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,293,624 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,562,080 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · derivative · entry 2 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 55,538 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · kind: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,293,624 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,562,080 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:00 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionCommon stock, par value $0.0001 per share | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-073984 · tm2417785-1_4seq1.xml · nonDerivative · entry 1 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,855,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Persons. F5 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2024, the date of the next annual meeting of the Company's stockholders following the grant date. F8 · balance_after: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F9 · balance_after: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F10 · balance_after: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,293,624 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,562,080 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F12 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. F14 · ownership.nature: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. Read SEC document |
| November 01, 2023 Filed Nov 14, 2023 21:47 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionRestricted Stock Units · Derivative | 17,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-118341 · tm2330765-1_4seq1.xml · derivative · entry 2 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 35,538 Underlying: Common stock, par value $0.0001 · 17,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F3 · kind: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Persons. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F4 · balance_after: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F10 · balance_after: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| November 01, 2023 Filed Nov 14, 2023 21:47 UTC | OmniAb, Inc. OABI · Entity 5294 | Exercise / conversionCommon stock, par value $0.0001 per share | 17,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-118341 · tm2330765-1_4seq1.xml · nonDerivative · entry 1 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 15,835,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Persons. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting occurs in three substantially equal annual installments, beginning November 1, 2023. F7 · balance_after: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F8 · balance_after: As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F9 · balance_after: Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F11 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. F13 · ownership.nature: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and other parties (the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 21:46 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantStock Options · Derivative | 40,000 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001104659-23-075413 · tm2319845-1_4seq1.xml · derivative · entry 5 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 40,000 Underlying: Common stock, par value $0.0001 · 40,000 shares Expires 2033-06-23 F6 · derivative.exercise_date: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · derivative.underlying_shares: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F6 · balance_after: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F6 · ownership.nature: Represents stock options granted to Mr. Tamaroff in his capacity as a director of the Issuer, which stock options vest and become exercisable in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F10 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 21:46 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-075413 · tm2319845-1_4seq1.xml · derivative · entry 4 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Notes Disclosed balance after: 20,000 Underlying: Common stock, par value $0.0001 · 20,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (i) the date of the next annual meeting of the Company's stockholders following the grant date and (ii) the first anniversary of the grant date. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V GP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F10 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 17:29 UTC | RVL Pharmaceuticals plc RVLP · Entity 108806 | OtherOrdinary Shares | 1,032,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-008079 · tm234889-2_4seq1.xml · nonDerivative · entry 1 Burgstahler David F · CIK 0001374179 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 F1 · kind: Represents shares distributed in kind by Orbit Co-Invest III LLC ("Orbit III") to its members, on a pro rata basis, for no consideration. F2 · ownership.nature: Represents shares of the Issuer held by Orbit III. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit III. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to have shared voting and investment power with respect to the shares held by Orbit III. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 20:54 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantCommon stock, par value $0.0001 per share | 53,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001606 · tm232303-1_4seq1.xml · nonDerivative · entry 1 Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,871,242 F5 · kind: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F5 · shares: Represents restricted stock units ("RSUs") granted to Mr. Tamaroff in his capacity as a director of the Issuer, which RSUs vest as to the shares underlying the award in three substantially similar annual installments beginning on November 1, 2023, subject to Mr. Tamaroff's continuing service as a director of the Issuer through the applicable vesting date; provided, that the RSUs shall vest in full (i) in the event of a Change of Control (as defined in the Issuer's 2022 Incentive Award Plan), to the extent Mr. Tamaroff is serving as a director at the time of such transaction, or (ii) in the event that Mr. Tamaroff ceases to serve as a director by reason of death or Permanent Disability (as defined in the Issuer's 2022 Incentive Award Plan). F3 · balance_after: In accordance with the letter agreement, dated March 23, 2022, by and among the Issuer, Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. As a result of the liquidation and distribution of all of the assets of the Avista Sponsor to its limited partners, ACP V Onshore and ACP V Offshore (the "Avista Sponsor Liquidating Distribution"), F4 · balance_after: and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. Additionally, in connection with the Avista Sponsor Liquidating Distribution, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), (ii) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), (iii) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, (iv) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (v) each of Thompson Dean and David Burgstahler, who are the managers of Avista Managing Member (together with ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (vi) Joshua Tamaroff, who is a director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F2 · ownership.nature: ACP V Onshore directly holds 7,283,484 shares of common stock and 5,224,114 warrants. ACP V Offshore directly holds 8,534,450 shares of common stock and 6,121,375 warrants. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F6 · ownership.nature: Mr. Tamaroff is a partner at an affiliate of the Avista Affiliates and has assigned all rights, title and interest in any securities of the Issuer to an affiliate of the Avista Affiliates controlled by Mr. Dean and Mr. Burgstahler. The Avista Affiliates, ACP V Onshore and ACP V Offshore are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Avista Affiliates and Mr. Tamaroff may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates, ACP V Onshore and ACP V Offshore and Mr. Tamaroff disclaims beneficial ownership of the securities issued to Mr. Tamaroff, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherWarrants · Derivative | 6,121,375 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · derivative · entry 7 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,121,375 Underlying: Common stock, par value $0.0001 · 6,121,375 shares Expires 2027-11-01 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F9 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · shares: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · price: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · derivative.exercise_date: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F5 · ownership.nature: Directly owned by ACP V Offshore. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherWarrants · Derivative | 5,224,114 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · derivative · entry 6 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 5,224,114 Underlying: Common stock, par value $0.0001 · 5,224,114 shares Expires 2027-11-01 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F9 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · shares: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · price: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · derivative.exercise_date: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F4 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherWarrants · Derivative | 11,345,489 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · derivative · entry 5 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Common stock, par value $0.0001 · 11,345,489 shares Expires 2027-11-01 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F9 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · shares: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · price: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F9 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms became exercisable (including by cash settlement) on December 1., 2022. F10 · derivative.exercise_date: In connection with the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and OmniAb, Inc.(the "A&R Forward Purchase Agreement"), Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms became exercisable (including by cash settlement) December 31, 2022. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherCommon stock, par value $0.0001 per share | 8,534,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · nonDerivative · entry 3 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 8,534,450 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F3 · price: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F6 · balance_after: In accordance with the letter agreement, dated March 23, 2022, among the Issuer, Avista Sponsor, Legacy OmniAb and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. As a result of the transactions described in this Form 4, and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F7 · balance_after: Additionally, in connection with the transactions described in this Form 4, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F5 · ownership.nature: Directly owned by ACP V Offshore. Each of the Avista Affiliates may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Avista Affiliates disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherCommon stock, par value $0.0001 per share | 7,283,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · nonDerivative · entry 2 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 7,283,484 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F3 · price: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F6 · balance_after: In accordance with the letter agreement, dated March 23, 2022, among the Issuer, Avista Sponsor, Legacy OmniAb and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. As a result of the transactions described in this Form 4, and pursuant to a Joinder to the Letter Agreement entered into on December 9, 2022 between ACP V Onshore, ACP V Offshore, Avista Sponsor and the Issuer, ACP V Onshore directly holds 595,508 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement, and ACP V Offshore holds 697,791 of the shares of common stock subject to forfeiture pursuant to the terms of the Letter Agreement. F7 · balance_after: Additionally, in connection with the transactions described in this Form 4, each of ACP V Onshore and ACP V Offshore provided to the Issuer an agreement stating that they will each be bound by the transfer restrictions included in the Amended and Restated Registration and Stockholder Rights Agreement, dated as of November 1, 2022, among the Issuer, the Sponsor and the other signatories thereto (the "A&R RSRA") for the duration of the Founder Shares Lock Up Period (as defined in the A&R RSRA). F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F4 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:35 UTC | OmniAb, Inc. OABI · Entity 5294 | OtherCommon stock, par value $0.0001 per share | 15,817,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-126643 · tm2232531-1_4seq1.xml · nonDerivative · entry 1 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Avista Capital Partners V, L.P. · CIK 0001774142 · Director · 10% owner Avista Capital Partners (Offshore) V, L.P. · CIK 0001774143 · Director · 10% owner Avista Capital Partners V GP, L.P. · CIK 0001957305 · Director · 10% owner Avista Capital Managing Member V, LLC · CIK 0001957307 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 F3 · shares: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F3 · price: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: (i) Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), (ii) Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista Sponsor GP"), which is the general partner of Avista Sponsor, (iii) Avista Capital Partners V, L.P., a Delaware limited partnership ("ACP V Onshore"), which is a limited partner of Avista Sponsor, (iv) Avista Capital Partners (Offshore) V, L.P., a Bermuda limited partnership ("ACP V Offshore"), which is a limited partner of Avista Sponsor, (v) Avista Capital Partners V GP, L.P., a Delaware limited partnership ("ACP V GP"), which is the general partner of ACP V Onshore and ACP V Offshore, F2 · ownership.nature: (vi) Avista Capital Managing Member V, LLC, a Delaware limited liability company ("Avista Managing Member"), which is the general partner of ACP V VP, (vii) each of Thompson Dean and David Burgstahler, who are the managers of Avista Sponsor GP and Avista Managing Member (together with ACP V Onshore, ACP V Offshore, ACP V GP and Avista Managing Member, the "Avista Affiliates"), and (viii) Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Each of the transactions described in this Form 4 are being made in connection with the liquidation and dissolution of Avista Sponsor and Avista Sponsor GP. In connection with its liquidation, Avista Sponsor distributed all of its assets, consisting solely of securities of the Issuer, pro rata for no consideration to its limited partners, ACP V Onshore and ACP V Offshore. As a result of these transactions and their subsequent dissolution, Avista Sponsor and Avista Sponsor GP will no longer hold, directly or indirectly, any securities in the Issuer. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:37 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantStock Option · Derivative | 161,849 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000899243-22-037741 · doc4.xml · derivative · entry 2 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Tamaroff Joshua Alexander · CIK 0001705548 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 161,849 Underlying: Common Stock · 161,849 shares Expires 2032-12-01 F3 · shares: Represents a stock option granted on December 1, 2022 to Joshua Tamaroff in his position as a Director of the Issuer, which vests in three substantially similar annual installments beginning on November 1, 2023. Mr. Tamaroff is a partner at Avista Capital Partners and has assigned all rights, title and interest in the stock option to the Avista Affiliates. The Avista Affiliates are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Reporting Persons may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F3 · derivative.exercise_date: Represents a stock option granted on December 1, 2022 to Joshua Tamaroff in his position as a Director of the Issuer, which vests in three substantially similar annual installments beginning on November 1, 2023. Mr. Tamaroff is a partner at Avista Capital Partners and has assigned all rights, title and interest in the stock option to the Avista Affiliates. The Avista Affiliates are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Reporting Persons may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista GP"), which is the general partner of Avista Sponsor, and Thompson Dean and David Burgstahler, who are the managers of Avista GP (together with Avista Sponsor and Avista GP, the "Avista Affiliates"), and Joshua Tamaroff, who is a Director of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer"). F3 · ownership.nature: Represents a stock option granted on December 1, 2022 to Joshua Tamaroff in his position as a Director of the Issuer, which vests in three substantially similar annual installments beginning on November 1, 2023. Mr. Tamaroff is a partner at Avista Capital Partners and has assigned all rights, title and interest in the stock option to the Avista Affiliates. The Avista Affiliates are each "directors by deputization" for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Each of the Reporting Persons may be deemed to beneficially own the securities reported on this line item to the extent of their respective pecuniary interests. Each of the Reporting Persons disclaims beneficial ownership of the securities reported on this line item, except to the extent of their pecuniary interest therein, if any. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 19:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantWarrants · Derivative | 11,345,489 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001104659-22-114525 · tm2229290-1_4seq1.xml · derivative · entry 2 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 11,345,489 Underlying: Common stock, par value $0.0001 · 11,345,489 shares Expires 2027-11-01 F5 · shares: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F6 · shares: In connection with the A&R Forward Purchase Agreement, Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F5 · price: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F6 · price: In connection with the A&R Forward Purchase Agreement, Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F5 · derivative.exercise_date: In connection with the completion of the Issuer's August 2021 initial public offering, Avista Sponsor purchased 8,233,333 warrants in a private placement from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one Class A ordinary share, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied upon the closing of the transactions contemplated by the Merger Agreement (the "Closing"), and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F6 · derivative.exercise_date: In connection with the A&R Forward Purchase Agreement, Avista Sponsor purchased an aggregate 3,112,156 warrants in private placements from the Issuer, each exercisable to purchase (subject, initially, to the satisfaction of certain material conditions) one share of common stock, par value $0.0001 per share, of the Issuer for $11.50 per share. The material conditions to exercise were satisfied on the Closing, and the warrants by their terms become exercisable (including by cash settlement) 30 days following the Closing. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista GP"), which is the general partner of Avista, and Thompson Dean and David Burgstahler, who are the managers of Avista GP. Because of the relationships among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F2 · ownership.nature: Directly owned by Avista Sponsor. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 19:00 UTC | OmniAb, Inc. OABI · Entity 5294 | GrantCommon stock, par value $0.0001 per share | 10,172,934 | $10.00 | $101,729,340.00 |
DisclosureSEC source: 0001104659-22-114525 · tm2229290-1_4seq1.xml · nonDerivative · entry 1 Avista Acquisition GP LLC II · CIK 0001846167 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Avista Acquisition LP II · CIK 0001846254 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,817,934 F3 · shares: Avista Sponsor acquired the shares of common stock of OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) (the "Issuer") in accordance with the Agreement and Plan of Merger, dated as of March 23, 2022 (the "Merger Agreement"), by and among the Issuer, Ligand Pharmaceuticals Incorporated, OmniAb, Inc. ("Legacy OmbiAb"), and Orwell Merger Sub Inc. and the Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among the Issuer, Avista Sponsor and Legacy OmniAb (the "A&R Forward Purchase Agreement"). F4 · balance_after: In accordance with the letter agreement, dated March 23, 2022, among the Issuer, Avista Sponsor, Legacy OmniAb and other parties (the "Letter Agreement"), if the Triggering Event (as defined in the Letter Agreement) has not occurred during the Earnout Period (as defined in the Letter Agreement), 1,293,299 shares of common stock will be automatically forfeited to the Issuer for no consideration. F1 · ownership.nature: This form is being filed by each of the following Reporting Persons: Avista Acquisition LP II, a Cayman Islands limited partnership ("Avista Sponsor"), Avista Acquisition GP LLC II, a Cayman Islands limited liability company ("Avista GP"), which is the general partner of Avista, and Thompson Dean and David Burgstahler, who are the managers of Avista GP. Because of the relationships among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. F2 · ownership.nature: Directly owned by Avista Sponsor. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 17:21 UTC | RVL Pharmaceuticals plc RVLP · Entity 108806 | PurchaseOrdinary Shares | 8,000,000 | $1.55 | $12,400,000.00 |
DisclosureSEC source: 0001104659-22-088033 · tm2222999-3_4seq1.xml · nonDerivative · entry 1 Burgstahler David F · CIK 0001374179 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 23,730,864 F1 · ownership.nature: Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Burgstahler is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:45 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A common stock | 21,154,526 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-017951 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 7,721,298 F2 · shares: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution"). F3 · shares: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution. F2 · price: Represents an aggregate of 9,664,970 shares of common stock distributed by ACP Onshore and 11,489,556 shares of common stock distributed by ACP Offshore, in each case, on a pro rata basis to their respective limited partners in accordance with their organizational documents for no additional consideration (the "Distribution"). F3 · balance_after: Represents an aggregate of 4,811,747 shares of common stock directly held by ACP Onshore and 2,909,551 shares of common stock directly held by ACP Offshore, in each case following the Distribution. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 24, 2020 Filed Nov 24, 2020 18:10 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 100 | $5.00 | $500.00 |
DisclosureSEC source: 0001140361-20-026482 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,924,515 F5 · shares: Represents an aggregate of 50 shares of Common Stock purchased by ACP Onshore and 50 shares of Common Stock purchased by ACP Offshore. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 17:11 UTC | RVL Pharmaceuticals plc OSMT · Entity 108806 | OtherOrdinary Shares | 4,936,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-128524 · a4.xml · nonDerivative · entry 1 Burgstahler David F · CIK 0001374179 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 F1 · kind: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Burgstahler is a member of the investment committee of ACP GP. As a result, Mr. Burgstahler ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. F1 · shares: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Burgstahler is a member of the investment committee of ACP GP. As a result, Mr. Burgstahler ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. F1 · price: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Burgstahler is a member of the investment committee of ACP GP. As a result, Mr. Burgstahler ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. F1 · ownership.nature: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Burgstahler is a member of the investment committee of ACP GP. As a result, Mr. Burgstahler ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 18:10 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 2,739 | $4.99 | $13,670.62 |
DisclosureSEC source: 0001140361-20-026482 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,924,415 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 1,373 shares of Common Stock purchased by ACP Onshore and 1,366 shares of Common Stock purchased by ACP Offshore. F4 · price: Purchase prices range from $4.98 to $5.00 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F6 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests Read SEC document |
| November 19, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 36,127 | $4.97 | $179,612.61 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 4 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,921,676 F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 18,111 shares of Common Stock purchased by ACP Onshore and 18,016 shares of Common Stock purchased by ACP Offshore. F10 · price: Purchase prices range from $4.86 to $5.00 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 18, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 45,378 | $4.68 | $212,518.79 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,885,549 F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · shares: Represents an aggregate of 22,747 shares of Common Stock purchased by ACP Onshore and 22,631 shares of Common Stock purchased by ACP Offshore. F8 · price: Purchase prices range from $4.58 to $4.75 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 50,000 | $4.45 | $222,405.00 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,840,171 F4 · shares: The number of securities reported represents an aggregate number of shares of Common Stock purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F5 · shares: Represents an aggregate of 25,065 shares of Common Stock purchased by ACP Onshore and 24,935 shares of Common Stock purchased by ACP Offshore. F6 · price: Purchase prices range from $4.38 to $4.50 per share, inclusive. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 19:14 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 4,272,657 | $3.25 | $13,886,135.25 |
DisclosureSEC source: 0001140361-20-026147 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 29,790,171 F2 · shares: Represents an aggregate of 2,142,071 shares of Class A common stock of the Issuer ("Common Stock") purchased by ACP Onshore and 2,130,586 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 17, 2020. F3 · price: Represents the public offering price of $3.25 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 12, 2020, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 18, 2020 and filed as Exhibit 10.1 thereto. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F11 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F12 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 16, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 75,000 | $3.98 | $298,132.50 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 4 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,517,514 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F12 · shares: Represents an aggregate of 37,601 shares of Common Stock purchased by ACP Onshore and 37,399 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F13 · price: Purchase prices range from $3.67 to $4.29 per share, inclusive. F14 · balance_after: Represents 12,267,300 shares of Common Stock owned directly by ACP Onshore, 12,201,523 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 135,000 | $4.31 | $581,283.00 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,442,514 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 67,681 shares of Common Stock purchased by ACP Onshore and 67,319 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F10 · price: Purchase prices range from $4.02 to $4.47 per share, inclusive. F11 · balance_after: Represents 12,229,699 shares of Common Stock owned directly by ACP Onshore, 12,164,124 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 141,462 | $4.17 | $590,377.51 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,307,514 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 70,921 shares of Common Stock purchased by ACP Onshore and 70,541 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $3.975 to $4.50 per share, inclusive. F8 · balance_after: Represents 12,162,018 shares of Common Stock owned directly by ACP Onshore, 12,096,805 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 21:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 190,887 | $3.62 | $691,163.65 |
DisclosureSEC source: 0001140361-20-005973 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 25,166,052 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 95,700 shares of Common Stock purchased by ACP Onshore and 95,187 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $2.98 to $3.97 per share, inclusive. F5 · balance_after: Represents 12,091,097 shares of Common Stock owned directly by ACP Onshore, 12,026,264 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F15 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F16 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 16:11 UTC | RVL Pharmaceuticals plc OSMT · Entity 108806 | PurchaseOrdinary Shares | 1,250,000 | $5.00 | $6,250,000.00 |
DisclosureSEC source: 0001104659-20-004323 · a4.xml · nonDerivative · entry 1 Burgstahler David F · CIK 0001374179 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 15,730,864 F1 · shares: Represents 1,250,000 Ordinary Shares acquired by Avista Healthcare Partners, L.P. ("AHP") in the Issuer's underwritten public offering (the "Offering") that was completed on January 13, 2020. The acquisition price of $5.00 per Ordinary Share represents the public offering price in the Offering paid by AHP and does not give effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of AHP, pursuant to the Fee Letter Agreement, dated January 8, 2020, among the Issuer, Avista Capital Holdings, L.P. and the other parties thereto, which was entered into in connection with the Offering. F1 · price: Represents 1,250,000 Ordinary Shares acquired by Avista Healthcare Partners, L.P. ("AHP") in the Issuer's underwritten public offering (the "Offering") that was completed on January 13, 2020. The acquisition price of $5.00 per Ordinary Share represents the public offering price in the Offering paid by AHP and does not give effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of AHP, pursuant to the Fee Letter Agreement, dated January 8, 2020, among the Issuer, Avista Capital Holdings, L.P. and the other parties thereto, which was entered into in connection with the Offering. F2 · ownership.nature: Represents shares of the Issuer held by AHP. Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Burgstahler is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 16:17 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 6,000,000 | $5.00 | $30,000,000.00 |
DisclosureSEC source: 0001140361-19-021634 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 24,975,165 F2 · shares: Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019. F3 · price: Represents the public offering price of $5.00 per share of Common Stock, without giving effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of the Avista Funds ("Avista Management"), pursuant to the Fee Letter Agreement, dated November 19, 2019, among the Issuer, Avista Management and the Avista Funds, made in connection with the Offering, as described in the Issuer's Current Report on Form 8-K filed on November 22, 2019 and filed as Exhibit 10.1 thereto. F2 · balance_after: Represents an aggregate of 3,008,064 shares of Common Stock purchased by ACP Onshore and 2,991,936 shares of Common Stock purchased by ACP Offshore in the Issuer's underwritten public offering (the "Offering") that was completed on November 26, 2019. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore" and together with ACP Onshore, the "Avista Funds"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F4 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 18:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 413,900 | $6.25 | $2,585,343.57 |
DisclosureSEC source: 0001140361-19-016669 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,975,165 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 207,507 shares of Common Stock purchased by ACP Onshore and 206,393 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $5.62 to $6.25 per share, inclusive. F8 · balance_after: Represents 8,987,333 shares of Common Stock owned directly by ACP Onshore, 8,939,141 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F9 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F10 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 11, 2019 Filed Sep 13, 2019 18:47 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 447,000 | $5.75 | $2,570,428.80 |
DisclosureSEC source: 0001140361-19-016669 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,561,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 224,101 shares of Common Stock purchased by ACP Onshore and 222,899 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $5.365 to $5.905 per share, inclusive. F5 · balance_after: Represents 8,779,826 shares of Common Stock owned directly by ACP Onshore, 8,732,748 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F9 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F10 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 10, 2019 Filed Sep 10, 2019 19:56 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 12,000 | $5.18 | $62,206.80 |
DisclosureSEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,114,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 6,016 shares of Common Stock purchased by ACP Onshore and 5,984 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F10 · price: Purchase prices range from $4.99 to $5.25 per share, inclusive. F11 · balance_after: Represents 8,555,725 shares of Common Stock owned directly by ACP Onshore, 8,509,849 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 09, 2019 Filed Sep 10, 2019 19:56 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 25,000 | $5.12 | $128,022.50 |
DisclosureSEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,102,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 12,534 shares of Common Stock purchased by ACP Onshore and 12,466 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $4.91 to $5.68 per share, inclusive. F8 · balance_after: Represents 8,549,709 shares of Common Stock owned directly by ACP Onshore, 8,503,865 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 19:56 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 500,000 | $5.18 | $2,592,300.00 |
DisclosureSEC source: 0001140361-19-016483 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,077,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 250,673 shares of Common Stock purchased by ACP Onshore and 249,327 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $4.73 to $5.35 per share, inclusive. F5 · balance_after: Represents 8,537,175 shares of Common Stock owned directly by ACP Onshore, 8,491,399 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 05, 2019 Filed Sep 5, 2019 18:51 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 177,600 | $4.89 | $868,570.56 |
DisclosureSEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 3 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 17,577,265 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F9 · shares: Represents an aggregate of 89,039 shares of Common Stock purchased by ACP Onshore and 88,561 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F10 · price: Purchase prices range from $4.52 to $4.90 per share, inclusive. F11 · balance_after: Represents 8,286,502 shares of Common Stock owned directly by ACP Onshore, 8,242,072 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 18:51 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 200,000 | $4.90 | $979,220.00 |
DisclosureSEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 17,399,665 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F6 · shares: Represents an aggregate of 100,269 shares of Common Stock purchased by ACP Onshore and 99,731 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F7 · price: Purchase prices range from $4.70 to $4.90 per share, inclusive. F8 · balance_after: Represents 8,197,463 shares of Common Stock owned directly by ACP Onshore, 8,153,511 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 18:51 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A common stock | 200,000 | $4.75 | $949,760.00 |
DisclosureSEC source: 0001140361-19-016217 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 17,199,665 F2 · shares: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F3 · shares: Represents an aggregate of 100,269 shares of Common Stock purchased by ACP Onshore and 99,731 shares of Common Stock purchased by ACP Offshore. F2 · price: The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. F4 · price: Purchase prices range from $4.44 to $4.75 per share, inclusive. F5 · balance_after: Represents 8,097,194 shares of Common Stock owned directly by ACP Onshore, 8,053,780 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. F12 · ownership.nature: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F13 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 17:05 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | Disposition to issuerWarrants (right to buy) · Derivative | 4,100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-19-015434 · form4.xml · derivative · entry 2 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 Underlying: Class A common stock · 2,050,000 shares Expires 2023-12-10 F5 · derivative.exercise_price: Each warrant entitled the holder to purchase from the Issuer shares of Common Stock at a price of $5.75 per-half share of Common Stock (or $11.50 per whole share), subject to adjustments. F2 · kind: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F2 · price: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thomspon Dean; and David Burgstahler. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 17:05 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantClass A common stock | 389,501 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-19-015434 · form4.xml · nonDerivative · entry 1 Avista Capital Managing Member IV, LLC · CIK 0001761175 · Director · 10% owner Avista Acquisition Corp. · CIK 0001661187 · Director · 10% owner Avista Acquisition, LLC · CIK 0001686388 · Director · 10% owner Avista Capital Partners IV, L.P. · CIK 0001664176 · Director · 10% owner Avista Capital Partners (Offshore) IV, L.P. · CIK 0001664173 · Director · 10% owner Avista Capital Partners IV GP, L.P. · CIK 0001761195 · Director · 10% owner Dean Thompson · CIK 0001069096 · Director · 10% owner Burgstahler David F · CIK 0001374179 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 16,999,665 F2 · kind: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F2 · price: Based on a ratio of 0.095 shares per warrant, ACP Onshore and ACP Offshore exchanged (with the Issuer) 2,055,510 warrants and 2,044,490 warrants, respectively, for 195,274 shares and 194,227 shares, respectively (the "Warrant Exchange"). F3 · balance_after: Represents 7,996,925 shares of Common Stock owned directly by ACP Onshore and 7,954,049 shares of Common Stock owned directly by ACP Offshore, in each case, following the Warrant Exchange, and 1,048,691 shares of Common Stock owned directly by the Sponsor. F4 · balance_after: Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests.Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. F1 · ownership.nature: This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thomspon Dean; and David Burgstahler. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.